RYTM
Rhythm Pharmaceuticals, Inc.
Stock
$92.83−0.58 (−0.62%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $67M
- YoY, 2025
- +68.4%
- 5-year CAGR
- +30.8%
- 10-year CAGR
- +71.8%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $67M | +68.4% |
| 2024 | $40M | +21.9% |
| 2023 | $33M | +64.2% |
| 2022 | $20M | −4.7% |
| 2021 | $21M | +19.2% |
| 2020 | $17M | +47.0% |
| 2019 | $12M | +85.8% |
| 2018 | $6.4M | +180.5% |
| 2017 | $2.3M | +95.0% |
| 2016 | $1.2M | +291.9% |
| 2015 | $298K | — |